Abstract:Major depressive disorder (MDD) is a serious mental disorder with unclear pathogenesis. ProBDNF is a precursor protein of brain derived neurotrophic factor (BDNF) expressed in the central nervous system and peripheral tissues. Previous studies showed that blood proBDNF levels in MDD were increased. However, the relationship between proBDNF/p75NTR and inflammatory cytokines in peripheral blood of MDD is unknown. The current study examined the expression of proBDNF and inflammatory markers in patients with major depression. Peripheral blood mononuclear cells (PBMCs) and serum were obtained from depressive patients (n = 32) and normal donors (n = 20). We examined the mRNA and protein expression of proBDNF/p75NTR/sortilin signaling pathway, as well as tumor necrosis factor α (TNF-α), interleukin-1β (IL-1β), interleukin-6 (IL-6), interleukin-10 (IL-10) in human PBMCs. The Enzyme-Linked Immunosorbent Assay (ELISA) levels of these factors in the sera were also examined. Furthermore, the correlations between each factor and severity of major depression were tested. Of biomarkers studies, we found that proBDNF, p75NTR and sortilin production were significantly increased in PBMCs from MDD patients compared with that from the normal donors. The upregulation of p75NTR in PBMCs was most obvious as determined by qPRC and Western blots. Interestingly, the expression of proBDNF/p75NTR/sortilin signaling pathway in PBMC could be reversed after therapeutic management. Inflammatory cytokines in PBMC from MDD patients were also increased. Consistently, ELISA showed that the levels of p75NTR, sortilin, IL-1β and IL-10 in the serum of major depression were also increased compared with normal donors, and positively correlated with the major depression scores. The levels of IL-1β and IL-10 were also positively correlated with the major depression scores. Intriguingly, the levels of sortilin was positively correlated with IL-1β. Further flow cytometry studies showed that the number of proBDNF and p75NTR positive CD4 + , CD8 + T cells and CD19 + B cells from MDD patients was increased and subsequently reversed after therapeutic management. The findings suggest that the upregulation of proBDNF/p75NTR/sortilin signaling pathway may relate to inflammatory markers in patients with major depression. Our data also suggest that proBDNF/p75NTR/sortilin signaling pathway may serve as biomarkers for MDD.

Relationship Between the Tryptophan-Kynurenine Pathway and Painful Physical Symptoms in Patients with Major Depressive Disorder

KXS Balances the Tryptophan Metabolism in Mild to Moderate Depressed Patients and Chronic Restraint Stress Induced Depressive Rats.

Increased Ratio of Mature BDNF to Precursor-Bdnf in Patients with Major Depressive Disorder with Severe Anhedonia.

Association of Anhedonia with Brain-Derived Neurotrophic Factor and Interleukin-10 in Major Depressive Disorder

The prevalence of painful physical symptoms in major depressive disorder: A systematic review and meta-analysis of observational studies.

Frontostriatal Circuitry and the Tryptophan Kynurenine Pathway in Major Psychiatric Disorders

Painful Physical Symptoms and Antidepressant Treatment Outcome in Depression: a Systematic Review and Meta-Analysis

Serum neuroactive metabolites of the tryptophan pathway in patients with acute phase of affective disorders

The kynurenine pathway in major depressive disorder under different disease states: A systematic review and meta-analysis

Dysbiosis of the Gut Microbiota and Kynurenine (Kyn) Pathway Activity as Potential Biomarkers in Patients with Major Depressive Disorder

Impact of Painful Physical Symptoms on First-Episode Major Depressive Disorder in Adults with Subthreshold Depressive Symptoms: A Prospective Cohort Study.

Association of the Serotonin and Kynurenine Pathways as Possible Therapeutic Targets to Modulate Pain in Patients with Fibromyalgia

The role and mechanism of tryptophan – kynurenine metabolic pathway in depression

The Tryptophan Catabolite or Kynurenine Pathway in a Major Depressive Episode with Melancholia, Psychotic Features and Suicidal Behaviors: A Systematic Review and Meta-Analysis

Understanding the kynurenine pathway: A narrative review on its impact across chronic pain conditions

Unlocking the Potential of the 3-Hydroxykynurenine/kynurenic Acid Ratio: a Promising Biomarker in Adolescent Major Depressive Disorder

Systematic Review of the Kynurenine Pathway and Psychoneurological Symptoms Among Adult Cancer Survivors

Depression, stress, and tryptophan metabolism through the kynurenine pathway: treatment strategies from the perspective of Chinese herbal medicine

Correlations Between Probdnf/p75ntr and Inflammatory Markers in Patients with Major Depression

Pre-treatment Pain Symptoms Influence Antidepressant Response to Ketamine in Depressive Patients

Associations among peripheral and central kynurenine pathway metabolites and inflammation in depression